These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6419061)
1. GABA system: clinical research and treatment of tardive dyskinesia. Thaker GK; Hare TA; Tamminga CA Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061 [No Abstract] [Full Text] [Related]
2. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications. Gale K; Casu M Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827 [No Abstract] [Full Text] [Related]
3. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188 [TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of tardive dyskinesia. Gunne LM; Häggström JE Psychopharmacology Suppl; 1985; 2():191-3. PubMed ID: 3858799 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia. Gaio JM; Pollak P; Hommel M; Perret J J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of striato-nigral GABAergic pathway by chronic haloperidol treatment: the role of dopamine D1 receptor in the substantia nigra pars reticulata on the development of tardive dyskinesia. Shirakawa O; Maeda K; Sakai K Jpn J Psychiatry Neurol; 1993 Jun; 47(2):429-30. PubMed ID: 8271625 [No Abstract] [Full Text] [Related]
9. Improvement in tardive dyskinesia after muscimol therapy. Tamminga CA; Crayton JW; Chase TN Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117 [TBL] [Abstract][Full Text] [Related]
10. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias. Andersson U; Häggström JE Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937 [TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)]. Arushanian EB Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951 [No Abstract] [Full Text] [Related]
12. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings]. Chien C; Jung K; Ross-Townsend A Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102 [No Abstract] [Full Text] [Related]
13. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders. Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199 [TBL] [Abstract][Full Text] [Related]
14. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia. Scheel-Krüger J; Arnt J Psychopharmacology Suppl; 1985; 2():46-57. PubMed ID: 2987907 [TBL] [Abstract][Full Text] [Related]
16. Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"? Kapit RM Med Hypotheses; 1977; 3(5):207-10. PubMed ID: 904502 [TBL] [Abstract][Full Text] [Related]
18. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Iadarola MJ; Gale K Mol Cell Biochem; 1981 Sep; 39():305-29. PubMed ID: 6273710 [No Abstract] [Full Text] [Related]
19. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037 [TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia: a role for the endogenous opioid system. Sandyk R Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]